摘要
目的:观察呼吸系统疾病治疗中应用盐酸氨溴索注射液治疗的临床效果。方法:选择60例呼吸系统疾病患者分为观察组和对照组,分别使用盐酸氨溴索注射液与布地奈德,比较两组患者治疗效果。结果:对照组总有效率(73.33%)低于观察组(96.66%),不良反应发生率(26.66%)高于观察组(6.66%)(P<0.05)。观察组吸痰次数低于对照组,住院时间、氧疗时间、症状改善时间均短于对照组(P<0.05)。结论:在呼吸系统疾病中应用盐酸氨溴索注射液治疗可获得显著效果,可有效降低患者不良反应发生率,提升总有效率,促进患者疾病快速康复。
Objective: To observe the clinical effect of ambroxol hydrochloride injection in the treatment of respiratory diseases. Methods: 60 patients with respiratory diseases were divided into observation group and control group. Patients in observation group were treated with ambroxol hydrochloride injection, while patients in control group were treated with budesonide, the therapeutic effects of the two groups were compared. Results: The total effective rate of the control group(73.33%) was lower than he observation group(96.66%), and the incidence of adverse reactions(26.66%) was higher than that of the observation group(6.66%)(P<0.05). The observation group had less sputum suction than the control group, and the hospitalization time, oxygen therapy time, and symptom improvement time were shorter than the control group(P<0.05). Conclusion: Ambroxol hydrochloride injection in the treatment of respiratory diseases can achieve remarkable results. It can effectively reduce the incidence of adverse reactions, improve the total effective rate, promote the rapid recovery of patients.
作者
蔡克敏
CAI Ke-min(Lushan People’s Hospital,Jiujiang Jiangxi 332000,China)
出处
《药品评价》
CAS
2019年第18期8-9,共2页
Drug Evaluation
关键词
呼吸系统疾病
盐酸氨溴索
布地奈德
Respiratory Diseases
Ambroxol Hydrochloride
Budesonide
